Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia

Tschaidse, Lea, Reisch, Nicole, Arlt, Wiebke, de la Perriere, Aude, Linden Hirschberg, Angelica, Juul, Anders, Mallappa, Ashwini, Merke, Deborah, Newell-Price, John, Perry, Colin, Prete, Alessandro, Rees, Aled ORCID: https://orcid.org/0000-0002-1165-9092, Stikkelbroeck, Nike, Touraine, Philippe, Coope, Helen, Porter, John, Ross, Richard and Quinkler, Marcus 2022. Modified-release hydrocortisone is associated with lower plasma renin activity in patients with salt-wasting congenital adrenal hyperplasia. European Journal of Endocrinology

PDF - Accepted Post-Print Version Download (380kB)

Item Type:	Article
Status:	In Press
Schools:	Medicine MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG)
Publisher:	European Society of Endocrinology
ISSN:	0804-4643
Date of First Compliant Deposit:	29 November 2022
Date of Acceptance:	24 November 2022
Last Modified:	02 Dec 2022 05:58
URI:	https://orca.cardiff.ac.uk/id/eprint/154555

Actions (repository staff only)

Edit Item